A new putative hepatitis virus has recently been discovered and termed
GB virus C (GBV-C). We investigated the prevalence of this virus amon
g 50 haemophiliacs treated with non-virus-inactivated clotting factor
concentrates prior to 1985 and 21 haemophiliacs treated exclusively wi
th virus-inactivated clotting factor concentrates. In the first group
the prevalence of GBV-C based on PCR and ELISA was 46%, In the second
group the prevalence of GBV-C was similar to that of healthy blood don
ors (5%). We therefore conclude that GBV-C is reliably inactivated by
modern virucidal methods such as vapour heating, pasteurization and tr
eatment with solvent/detergent mixtures.